STATESVILLE, N.C., Dec. 18, 2020 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today reported that the Kewaunee International Group was honored by the Confederation of Indian Industry ("CII") in the category of "Customer Centricity" in a function held at National Conference on Consumer Awareness & Protection in Digital era – The New Normal, Customer Obsession awards ceremony on 15th December 2020 in India.
"Kewaunee International was again recognized by CII as an industry leader in customer excellence, recognizing our team's unwavering focus on serving our customers. As the market leader in laboratory furniture and technical products, we recognize the importance of delighting our customers in all aspects of their dealings with Kewaunee. Earning this award during the coronavirus pandemic makes the award even more special and reflects the resilience of the Kewaunee International team during an unprecedented year," said Mr. B. Sathya Murthy, Managing Director & Vice President – International Operations, Kewaunee Scientific Corporation.
"Everything we do begins and ends with our customers and our desire to repeatedly earn their trust as they invest in projects that require the specialized laboratory furniture and technical products in which Kewaunee specializes," said Thomas D. Hull III, President and Chief Executive Officer of Kewaunee Scientific Corporation. "As Sathya so rightly highlighted, our Kewaunee Associates being recognized for this award is indeed special; however, receiving the recognition of CII during 2020 is especially rewarding. I continue to be amazed by our Associates' desire to make our customer experience the best in the industry."
Recognition was based on the assessment made by a team of qualified judges from CII and was done based on CII-IQ Functional Excellence framework to understand the maturity level of practices and associated results of the function. The framework requirements were broadly covered in the Self-Assessment Questionnaire of the respective theme. As such, scoring was done broadly in line with the guidelines of EFQM and Baldrige Excellence Framework.
About Kewaunee Scientific
Founded in 1906, Kewaunee Scientific Corporation is a recognized global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. The Company's products include steel, wood, and laminate casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, laminar flow cabinets, and epoxy resin worksurfaces and sinks.
The Company's corporate headquarters are located in Statesville, North Carolina. Direct sales offices are located in the United States, India and Singapore. Three manufacturing facilities are located in Statesville serving the domestic and international markets, and one manufacturing facility is located in Bangalore, India serving the local and Asian markets. Kewaunee Scientific's website is located at http://www.kewaunee.com.
This press release contains statements that the Company believes to be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included in this press release, including statements regarding the Company's future financial condition, results of operations, business operations and business prospects, are forward-looking statements. Words such as "anticipate," "estimate," "expect," "project," "intend," "plan," "predict," "believe" and similar words, expressions and variations of these words and expressions are intended to identify forward-looking statements. Such forward-looking statements are subject to known and unknown risks, uncertainties, assumptions, and other important factors that could significantly impact results or achievements expressed or implied by such forward-looking statements. Such factors, risks, uncertainties and assumptions include, but are not limited to, competitive and general economic conditions and the rapidly evolving COVID-19 pandemic, including disruptions from government mandates, both domestically and internationally; changes in customer demands; technological changes in our operations or in our industry; dependence on customers' required delivery schedules; risks related to fluctuations in the Company's operating results from quarter to quarter; risks related to international operations, including foreign currency fluctuations; changes in the legal and regulatory environment; changes in raw materials and commodity costs; and acts of terrorism, war, governmental action, natural disasters and other Force Majeure events. The cautionary statements made pursuant to the Reform Act herein and elsewhere by us should not be construed as exhaustive. We cannot always predict what factors would cause actual results to differ materially from those indicated by the forward-looking statements. Over time, our actual results, performance, or achievements will likely differ from the anticipated results, performance or achievements that are expressed or implied by our forward-looking statements, and such difference might be significant and harmful to our stockholders' interest. Many important factors that could cause such a difference are described under the caption "Risk Factors," in Item 1A of our Annual Report on Form 10-K for the fiscal year ended April 30, 2020, which you should review carefully, and in our subsequent quarterly reports on Form 10-Q and current reports on Form 8-K. These reports are available on our investor relations website at www.kewaunee.com and on the SEC website at www.sec.gov. These forward-looking statements speak only as of the date of this document. The Company assumes no obligation, and expressly disclaims any obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise.
Donald T. Gardner III
SOURCE Kewaunee Scientific Corporation